In this study, we evaluated the performance of ODxTT and cobas EGFR in detecting EGFR mutations, which is essential for the assessment of advanced NS‐NSCLC patients, because the frequency of EGFR mutations associated with this disease is high. This evidence concerns the gene EGFR and non-small cell lung carcinoma.